04/17/2023
https://congress.gov...
"I look forward to working with my colleagues to advance bipartisan reform that will actually lower drug prices."
"data challenges we identified in our 2008 report continue to make it difficult for FDA to accurately identify establishments subject to inspection."
"I think that'd be really helpful."
"I am, frankly, very concerned by this implication that, since it is an international problem... we should somehow just sit around."